Outcomes of the Intradural Extramedullary Tumors Resection
Professor of Neurosurgery
Professor of Neurosurgery
Sponsor study identifier
interventional
24
0 countries
N/A
Study Start
April 1, 2008
Actual (reported)Primary Completion
April 1, 2015
Actual (reported)Study Completion
April 8, 2015
Actual (reported)The intradural extramedullary tumors remain curable diseases. Our aim in this study is to evaluate the postoperative status after the tumor resection and compare it to the preoperative status
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 8, 2015
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 1, 2008
Actual (reported)April 1, 2015
Actual (reported)April 8, 2015
Actual (reported)March 28, 2020
Actual (reported)April 2, 2020
Actual (reported)complete excision
delicate dissection
7 years
Excision of intradural tumors
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
24 participants (actual enrollment reported by the registry).
First Submitted
March 28, 2020
First Posted
April 2, 2020
Study Start
April 1, 2008
Actual (reported)Development of the MDASI-Spine Tumor Module
Contact the study team to confirm eligibility.
Primary Completion
April 1, 2015
Actual (reported)Study Completion
April 8, 2015
Actual (reported)Last Updated
April 2, 2020
Record last verified: 2020-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: